Apiam Animal Health (ASX: AHX) has announced a strategic partnership with the German company Veyx-Pharma to distribute their cutting-edge products across Australia. This agreement marks a significant milestone for both companies as they expand their reach and bring new technology to the Australian market.
Over the past six months, Apiam has been rigorously researching Veyx-Pharma’s lead product, with a particular focus on its applications for Australian pig farmers. The culmination of this research will be the product’s launch in the Australian pig industry, slated to occur within the next few months. This innovative product is anticipated to bring substantial benefits to local farmers, enhancing productivity.
Apiam’s CEO, Dr Chris Richards, expressed his enthusiasm for the partnership. “We are extremely excited to bring Veyx-Pharma’s advanced technology to Australia. This collaboration allows us to provide our farmers with state-of-the-art solutions that can significantly improve their operations,” said Dr Richards.
Veyx-Pharma, known for its innovative approach and high-quality products in animal health, sees this partnership as a significant step towards global expansion. Dr Silke Engl, CEO of Veyx-Pharma was equally enthused.
“This is an exciting opportunity for Veyx-Pharma. Expanding into the Australian market allows us to support veterinarians and farmers with our advanced solutions, fostering better animal health and productivity outcomes in a new region,” said Dr Engl.
The introduction of Veyx-Pharma’s products in Australia is expected to set a new benchmark in the industry, particularly within the pig farming sector. Apiam’s established network and expertise in the local market, combined with Veyx-Pharma’s innovative products, promise a fruitful collaboration that will benefit the Australian agriculture industry.
As the launch date approaches, both companies are committed to ensuring a smooth rollout and providing comprehensive support to Australian farmers, guaranteeing the successful integration of these new products into their farming practices. This partnership not only signifies growth and innovation but also reinforces the shared commitment of Apiam and Veyx-Pharma to advancing animal health and farm productivity globally.
Mitch Korver is a Business Writer focused on high-growth companies listed on the ASX in the small and medium cap space.
Latest posts by Mitchell Korver (see all)
- Harris Technology continues growth with refurbished tech sales surpassing second $1M in just three months - October 28, 2024
- Income Asset Management flags positive cashflow via strategic platform partnership with Perpetual - October 7, 2024
- NobleOak acquires RevTech and FiftyUp Club in $11 million deal that ceases life insurance commission payments - October 2, 2024
1 Comment
Shraddha13
Thank you for sharing! To explore further
Replyhttps://www.360iresearch.com/library/intelligence/companion-animal-health